One-Year Outcomes Comparing Anti-Vegf Monotherapy and Combined Anti-VEGF+Photodynamic Therapy for Retinal Angiomatous Proliferation

Beyoglu Eye Journal
doi 10.14744/bej.2017.46036
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Kare Publishing

Related search

Long-Term Visual and Anatomical Outcomes Following Anti-Vegf Monotherapy for Retinal Angiomatous Proliferation

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2009English

Anti-Vegf Therapy in Central Retinal Vein Occlusions

International Journal of Retina
2018English

Sequenced Combined Intravitreal Triamcinolone and Indocyanine Green Angiography–Guided Photodynamic Therapy for Retinal Angiomatous Proliferation

Archives of Ophthalmology
2006English

Predictive Factors and Long-Term Visual Outcomes After Anti-Vascular Endothelial Growth Factor Treatment of Retinal Angiomatous Proliferation

Clinical Ophthalmology
Ophthalmology
2019English

Ocular Anti-Vegf Therapy for Diabetic Retinopathy: The Role of VEGF in the Pathogenesis of Diabetic Retinopathy

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2014English

Use of Biomaterials for Sustained Delivery of Anti-Vegf to Treat Retinal Diseases

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2020English

Effect of Anti-Vegf Antibody on Retinal Ganglion Cells in Rats

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2007English

Anti-Vegf Therapies in the Clinic

Cold Spring Harbor perspectives in medicine
BiochemistryMedicineGeneticsMolecular Biology
2012English

Anti-Angiogenic Alternatives to VEGF Blockade

Clinical and Experimental Metastasis
MedicineCancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy